ASLN   $0.6  -14.27% Market Closed

Aslan Pharmaceuticals Ltd

EMA (20): 2024-07-15 the price crossed down the moving average line and formed a short-term downside trend.

EMA (50): 2024-03-22 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (100): 2024-03-12 the price crossed down the moving average line and demonstrates a strong downside trend.

RSI: RSI indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: signal line crossed the middle level.

Trend Type down and flat
Power strong
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -56.52%
EMA (20) date of signal July 15, 2024, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -88.51%
EMA (50) date of signal March 22, 2024, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -88.93%
EMA (100) date of signal March 12, 2024, 3 a.m.
RSI Signals bearish recovery
RSI (14) Yield -56.52%
RSI (14) date of signal July 15, 2024, 3 a.m.
MACD Signals bearish recovery
MACD Yield -56.52%
MACD date of signal July 15, 2024, 3 a.m.
Stochastic Signals bearish
Stochastic Yield -14.27%
Stochastic date of signal July 17, 2024, 3 a.m.
Updated July 24, 2024, 11 p.m.